Aegis Capital Reiterates Buy Rating on Neuralstem Following 2Q13 Financial Results
August 16, 2013 at 10:49 AM EDT
In a report published Friday, Aegis Capital analyst Brian Rockowitz reiterated a Buy rating and $4.00 price target on Neuralstem (NYSE: CUR ). In the report, Aegis Capital noted, “Last week, Neuralstem reported financial results for the second quarter of 2013. The firm closed the quarter with $11.2mm in cash
